What Researchers Did
This study investigated the effect of hyperbaric oxygen treatment on cardiac injury by measuring high-sensitivity cardiac troponin T levels in 48 individuals undergoing 30 exposures for non-cardiac pathologies.
What They Found
Researchers found no clinically significant difference in high-sensitivity cardiac troponin T measurements following acute or recurrent sequential exposures to hyperbaric oxygen in 48 individuals.
This indicates that profound hyperoxia did not induce measurable cardiac injury at a biochemical level, nor did it show a cardioprotective effect.
What This Means for Canadian Patients
Canadian patients receiving hyperbaric oxygen treatment for non-cardiac conditions can be reassured that this therapy appears safe for the heart.
The findings suggest that hyperbaric oxygen does not cause cardiac injury, even in those with pre-existing heart conditions or risk factors.
Canadian Relevance
This study has no direct Canadian connection as it was not conducted in Canada, nor did it involve Canadian researchers or patients.
Study Limitations
The study's assessment of cardiac injury was limited to biochemical markers (troponin T) and did not include other potential indicators of cardiac stress or long-term outcomes.